Has Padraic McCahill, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,261 in general payments to Padraic McCahill, MD across 408 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Padraic McCahill, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Padraic McCahill, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Padraic McCahill, MD

Urology · North Easton, MANPI 1730186693

Payments from drug & device makers

$12,261in general payments, 2019–2025

Across 408 payments — averaging $30.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gyrus ACMI, Inc.$3K
Astellas Pharma US Inc$1K
Teleflex LLC$636
Antares Pharma, Inc.$507
Endo Pharmaceuticals Inc.$456
Johnson & Johnson$438
plus $6K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gyrus ACMI, Inc.	1	$2,500
Astellas Pharma US Inc	67	$1,371
Teleflex LLC	25	$636
Antares Pharma, Inc.	17	$507
Endo Pharmaceuticals Inc.	22	$456
Johnson & Johnson(2 entities)	15	$438
Pfizer	20	$437
Sumitomo Pharma America, Inc.	18	$393
Tolmar, Inc.	16	$352
AbbVie(2 entities)	14	$339
Urogen Pharma, Inc.	10	$330
Ferring Pharmaceuticals Inc.	12	$283
Endo USA, Inc.	10	$264
Myriad Genetic Laboratories, Inc.	16	$257
Neotract Inc.	9	$252
C. R. Bard, Inc. & Subsidiaries	4	$246
Immunitybio, Inc.	10	$244
Accord Healthcare, Inc.	10	$237
180 Medical, Inc.	8	$215
Dendreon Pharmaceuticals LLC	10	$204
Boston Scientific	7	$178
Coloplast	7	$170
Urovant Sciences Inc	7	$164
Laborie Medical Technologies Corp.	4	$155
Progenics Pharmaceuticals, Inc.	6	$143
Healthtronics Stone Solutions, LLC	1	$130
Dentsply IH AB	4	$116
Acerus Pharmaceuticals Corporation	6	$98
ABC Home Medical Supply, Inc.	4	$96
Merck	3	$91
Blue Earth Diagnostics	4	$83
Tolmar Pharmaceuticals, Inc.	4	$80
Myovant Sciences Inc.	4	$79
Hollister Incorporated	3	$68
Convatec Inc.	2	$67
Mission Pharmacal Company	3	$62
Bioprotect Medical, Inc.	2	$60
Telix Pharmaceuticals	2	$43
Olympus America Inc.	2	$39
Axonics, Inc.	2	$37
Valencia Technologies Corporation	2	$33
Bayer	1	$32
Kowa Pharmaceuticals America, Inc.	2	$31
AstraZeneca	1	$28
Procept Biorobotics Corporation	1	$26
Caris MPI, Inc.	1	$25
Otsuka America Pharmaceutical, Inc.	1	$24
Palette Life Sciences, Inc.	1	$21
Novartis	1	$21
Metuchen Pharmaceuticals	1	$20
Medtronic	1	$19
BD	1	$17
Alnylam Pharmaceuticals Inc.	1	$15
Calyxo, Inc.	1	$15
Sanofi	1	$13

How this compares

$12,261 in reported general payments places this provider in the 80th percentile of 327 urology providers in Massachusetts.

See all urology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$560,962

Medicare patients

1,045

Services billed

14,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in North Easton

James FitzgeraldNorth Easton$16K
Natalya LopushnyanNorth Easton$12K
Ryan FrankelNorth Easton$11K
Christopher CutieBoston$3.5M
Henry MitchesonWatertown$1.6M
Brian EisnerBoston$1.4M
Mark PrestonBoston$1.2M
David StaskinBrighton$807K
Abraham MorgentalerChestnut Hill$522K
Alejandro SanchezBoston$349K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →